PROM1 and cancer: In addition, the elimination of CD133+TAZ+ cells could be obtained through the delivery of anti-miRNA using RNA nanoparticles targeting CD133, a treatment that, in preclinical models, induced the massive apoptosis of CD133+ cancer cells [66].